The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 26, 2021

Filed:

Dec. 06, 2016
Applicant:

General Oncology, Inc., Newton, MA (US);

Inventor:

Arnold Glazier, Newton, MA (US);

Assignee:

General Oncology, Inc., Newton, MA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/375 (2006.01); A61K 31/714 (2006.01); A61K 31/198 (2006.01); A61P 35/04 (2006.01); A61K 31/17 (2006.01); A61K 45/06 (2006.01); A61K 31/045 (2006.01);
U.S. Cl.
CPC ...
A61K 31/17 (2013.01); A61K 31/045 (2013.01); A61K 31/198 (2013.01); A61K 31/375 (2013.01); A61K 31/714 (2013.01); A61K 45/06 (2013.01); A61P 35/04 (2018.01); A61K 2300/00 (2013.01);
Abstract

The present invention relates to methods and sets of drugs for the effective treatment of metastatic cancer and the administration of a set of drugs that overcome mechanisms of resistance to DNA-damaging agents, thereby sensitizing cancer cells to said DNA-damaging agents. The methods involve the administration of a set of drugs comprising melphalan, BCNU, hydroxocobalamin, and ascorbic acid. In a preferred embodiment, ethanol is also added to the set of drugs and bone marrow toxicity is reversed with an infusion of bone marrow stem cells. The methods also involve the depletion of GSH in tumors and the selective delivery of drugs to solid tumors. The methods also involve preventing the loss of catalase function and preventing oxidant-induced hemolysis and/or methemoglobin formation in subjects treated with oxidant drugs or agents that generate hydrogen peroxide, wherein said methods comprise the systemic administration of ethanol.


Find Patent Forward Citations

Loading…